Ubs Group Ag Teva Pharmaceutical Industries LTD Call Options Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

Call Options

19 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$15.81 - $18.96 $607,104 - $728,064	-38,400 Reduced 36.47%	66,900 $1.21 Million
Q2 2024 Aug 13, 2024	BUY	$12.78 - $17.4 $490,752 - $668,160	38,400 Added 57.4%	105,300 $1.71 Million
Q1 2024 May 13, 2024	BUY	$10.67 - $14.43 $713,823 - $965,367	66,900 New	66,900 $943,000
Q1 2023 May 12, 2023	BUY	$8.36 - $11.37 $1.17 Million - $1.59 Million	139,600 Added 231.13%	200,000 $1.77 Million
Q2 2022 Aug 10, 2022	BUY	$7.38 - $10.4 $205,902 - $290,160	27,900 Added 85.85%	60,400 $454,000
Q1 2021 May 12, 2021	SELL	$10.34 - $12.81 $4.61 Million - $5.71 Million	-445,700 Reduced 93.2%	32,500 $375,000
Q4 2020 Feb 11, 2021	BUY	$8.61 - $11.04 $2.25 Million - $2.88 Million	261,300 Added 120.47%	478,200 $4.62 Million
Q1 2020 May 01, 2020	SELL	$6.69 - $13.45 $735,231 - $1.48 Million	-109,900 Reduced 33.63%	216,900 $1.95 Million
Q3 2019 Nov 14, 2019	BUY	$6.16 - $9.6 $1.71 Million - $2.66 Million	276,800 Added 553.6%	326,800 $2.25 Million
Q2 2019 Aug 14, 2019	SELL	$8.12 - $15.72 $2.7 Million - $5.22 Million	-332,100 Reduced 86.91%	50,000 $462,000
Q1 2019 May 14, 2019	BUY	$15.58 - $20.01 $4.91 Million - $6.31 Million	315,400 Added 472.86%	382,100 $5.99 Million
Q4 2018 Feb 14, 2019	SELL	$14.59 - $23.84 $262,620 - $429,120	-18,000 Reduced 21.25%	66,700 $1.03 Million
Q3 2018 Nov 14, 2018	SELL	$21.06 - $25.65 $532,818 - $648,945	-25,300 Reduced 23.0%	84,700 $1.82 Million
Q2 2018 Aug 14, 2018	SELL	$16.77 - $24.71 $268,320 - $395,360	-16,000 Reduced 12.7%	110,000 $2.68 Million
Q1 2018 May 15, 2018	SELL	$16.68 - $22.07 $16.4 Million - $21.7 Million	-981,800 Reduced 88.63%	126,000 $2.15 Million
Q4 2017 Feb 14, 2018	BUY	$11.23 - $19.1 $6.99 Million - $11.9 Million	622,500 Added 128.27%	1,107,800 $21 Million
Q3 2017 Nov 14, 2017	SELL	$15.41 - $32.17 $510,225 - $1.07 Million	-33,110 Reduced 6.39%	485,300 $8.54 Million
Q2 2017 Aug 14, 2017	SELL	N/A	-815,190 Reduced 61.13%	518,410 $17.2 Million
Q1 2017 Nov 14, 2017	BUY	N/A	1,333,600	1,333,600 $42.8 Million

Others Institutions Holding TEVA

# of Institutions

625

Shares Held

573M

Call Options Held

19.6M

Put Options Held

6.77M

Black Rock Inc. New York, NY

43M
Shares

$964 Million
0.02% of portfolio
Ion Asset Management Ltd. George Town, Grand Cayman, E9

36.2M
Shares

$813 Million
35.87% of portfolio
Clal Insurance Enterprises Holdings LTD Tel Aviv, L3

34.5M
Shares

$774 Million
5.5% of portfolio
Menora Mivtachim Holdings Ltd.

28.8M
Shares

$647 Million
3.32% of portfolio
Exor Capital LLP London, X0

26.5M
Shares

$594 Million
14.79% of portfolio

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $24.9B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account